Global Animal Blood Plasma and Derivatives Market Size By Type (Immunoglobulin, Fibrinogen), By Application (Food And Beverages, Pharmaceuticals), By Region, And Segment Forecasts, 2023 to 2032

The Global Animal Blood Plasma and Derivatives Market was valued at USD 2.3 billion in 2023 and is projected to surpass USD 3.9 billion by 2031, growing at a CAGR of 6.8% during the forecast period from 2023 to 2031. Animal blood plasma and derivatives are increasingly utilized in various sectors including animal feed, pharmaceuticals, food, and diagnostics due to their high protein content and functional properties such as emulsification, gelling, and binding. The demand is particularly growing in livestock nutrition and health management, driven by a global emphasis on sustainable animal production and bio-based ingredient applications.

Drivers:

1. Rising Demand for Functional Animal Feed Ingredients:

Animal plasma is being incorporated into feed to improve gut health, immunity, and growth performance, particularly in piglets and poultry, creating robust demand across developed and emerging economies.

2. Growth in Pet Nutrition and Veterinary Healthcare:

The growing pet population and increased spending on premium pet food and healthcare services are driving the adoption of blood derivatives in veterinary formulations and functional treats.

3. Expanding Applications in Pharmaceuticals and Biotechnology:

Animal plasma derivatives such as immunoglobulins and fibrinogen are used in pharmaceutical and biotechnological processes including cell culture, wound healing, and vaccine production.

Restraints:

1. Ethical and Regulatory Concerns:

The sourcing of animal blood components may raise ethical questions and face stringent regulatory scrutiny, especially in Europe and North America, which can hinder product acceptance and commercialization.

2. Risk of Pathogen Transmission:

There remains a concern regarding the potential for disease transmission through blood-derived products, necessitating rigorous processing and quality control standards, which can increase costs.

Opportunity:

1. Emerging Market Adoption in Asia-Pacific and Latin America:

Increasing industrial livestock farming and supportive government policies for sustainable agriculture in countries like China, India, and Brazil offer significant expansion opportunities.

2. Innovations in Plasma Processing Technologies:

Advancements in spray-drying, microfiltration, and fractionation techniques are enhancing product quality and expanding the functional uses of plasma derivatives across diverse industries.

Market by System Type Insights:

Based on product type, Spray-Dried Plasma (SDP) dominated the market in 2023. SDP is widely used in animal feed due to its digestibility and immune-modulating benefits, making it highly effective in early-weaning diets and disease-prone livestock systems. It is expected to maintain its leadership during the forecast period.

Market by End-use Insights:

In terms of end-use, the Animal Feed Industry accounted for the largest market share in 2023. The inclusion of plasma in swine and poultry feed to promote health, feed efficiency, and growth is the key driver. However, the Pharmaceutical and Biotechnology segment is poised for the fastest growth, fueled by increasing demand for animal-derived proteins in medical applications.

Market by Regional Insights:

North America led the global market in 2023, owing to high meat consumption, advanced animal health practices, and established processing infrastructure. Meanwhile, Asia-Pacific is projected to exhibit the highest CAGR during the forecast period, supported by a rapidly expanding livestock industry, urbanization, and rising consumer awareness of food safety and animal health.

Competitive Scenario:

Prominent players in the Global Animal Blood Plasma and Derivatives Market include APC Inc., Sera Scandia A/S, Lican Food, Sonac (Darling Ingredients Inc.), Veos Group, Kraeber & Co GmbH, and Bioiberica S.A.U. These companies are actively investing in R&D, expanding production capacities, and forming strategic alliances to diversify their product portfolios and strengthen their market presence.

Scope of Work – Global Animal Blood Plasma and Derivatives Market

Key Market Developments:

2023: APC Inc. launched a new range of hydrolyzed plasma proteins targeted at immune support in early-weaned piglets and stressed poultry populations.

2024: Darling Ingredients (Sonac) announced the expansion of its European blood plasma processing facilities to meet rising demand in pet food and biotech applications.

2023: Veos Group entered a strategic partnership with a leading animal nutrition company in South America to expand its product reach and innovate species-specific plasma formulas.

FAQs:

1. What is the current market size of the Global Animal Blood Plasma and Derivatives Market?

The market was valued at USD 2.3 billion in 2023.

2. What is the major growth driver of the Global Animal Blood Plasma and Derivatives Market?

The rising demand for functional animal feed ingredients and pharmaceutical applications is a key growth driver.

3. Which is the largest region during the forecast period in the Global Animal Blood Plasma and Derivatives Market?

North America holds the largest share, while Asia-Pacific is expected to grow the fastest.

4. Which segment accounted for the largest market share in Global Animal Blood Plasma and Derivatives Market?

The Animal Feed segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Animal Blood Plasma and Derivatives Market?

Key players include APC Inc., Sera Scandia A/S, Lican Food, Sonac (Darling Ingredients), Veos Group, and Bioiberica S.A.U.